Jushi Holdings (JUSHF) Total Non-Current Liabilities (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Total Non-Current Liabilities came in at $494.8 million in Q1 2026, up 12.74% year-on-year from $438.9 million in Q1 2025, and up 4.95% on a QoQ basis from $471.5 million in Q4 2025.

Jushi Holdings (JUSHF) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Total Non-Current Liabilities data on file, last reported at $494.8 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 12.74% year-over-year to $494.8 million in Q1 2026; TTM through Mar 2026 was $494.8 million, a 12.74% increase from a year earlier, with the FY2025 full-year figure at $471.5 million, up 11.82% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $494.8 million, up from $471.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for JUSHF reached as high as $494.8 million in Q1 2026 and fell as low as $259.3 million in Q3 2022.
  • Historically, Total Non-Current Liabilities has averaged $382.6 million across 5 years, with a median of $375.8 million in 2022.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 40.61% in 2023 and fell as far as 17.9% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $375.8 million in 2022, then slipped by 17.9% to $308.6 million in 2023, then soared by 36.66% to $421.7 million in 2024, then gained by 11.82% to $471.5 million in 2025, then climbed by 4.95% to $494.8 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $494.8 million in Q1 2026, $471.5 million in Q4 2025, and $424.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 494.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 494.85 Mn
Dec 31, 2025 471.50 Mn
Sep 30, 2025 423.98 Mn
Jun 30, 2025 447.08 Mn
Mar 31, 2025 438.92 Mn
Dec 31, 2024 421.66 Mn
Sep 30, 2024 411.23 Mn
Jun 30, 2024 405.29 Mn
Mar 31, 2024 317.14 Mn
Dec 31, 2023 308.55 Mn
Sep 30, 2023 364.58 Mn
Jun 30, 2023 346.39 Mn
Mar 31, 2023 368.98 Mn
Dec 31, 2022 375.82 Mn
Sep 30, 2022 259.28 Mn
Jun 30, 2022 330.09 Mn
Mar 31, 2022 318.06 Mn
Dec 31, 2021 387.14 Mn